AGNELLI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 10344
NA - Nord America 7181
AS - Asia 3257
SA - Sud America 156
OC - Oceania 24
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20975
Nazione #
US - Stati Uniti d'America 7001
GB - Regno Unito 3856
DE - Germania 2654
CN - Cina 2037
IT - Italia 1238
SE - Svezia 856
UA - Ucraina 406
TR - Turchia 387
FR - Francia 362
KR - Corea 314
RU - Federazione Russa 309
IN - India 273
EU - Europa 241
NL - Olanda 190
FI - Finlandia 173
CA - Canada 169
CO - Colombia 123
DK - Danimarca 86
JP - Giappone 66
VN - Vietnam 57
PL - Polonia 54
GR - Grecia 53
ID - Indonesia 29
BE - Belgio 22
AU - Australia 21
RO - Romania 20
HK - Hong Kong 17
CH - Svizzera 16
IR - Iran 14
TW - Taiwan 14
ES - Italia 13
CL - Cile 12
UZ - Uzbekistan 12
BR - Brasile 11
MX - Messico 11
SG - Singapore 10
NO - Norvegia 7
PE - Perù 6
BG - Bulgaria 5
PT - Portogallo 5
TH - Thailandia 5
EG - Egitto 4
GE - Georgia 4
HU - Ungheria 4
JO - Giordania 4
MY - Malesia 4
CZ - Repubblica Ceca 3
IE - Irlanda 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AR - Argentina 2
IL - Israele 2
LT - Lituania 2
PK - Pakistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
EC - Ecuador 1
HR - Croazia 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
Totale 21215
Città #
Southend 3459
Boise 651
Seattle 617
Beijing 575
Milan 523
Chandler 487
Fairfield 439
Wilmington 438
Princeton 417
Jacksonville 340
Houston 286
Dearborn 276
Woodbridge 275
Hanover 271
Ashburn 263
Mountain View 248
Redmond 219
Nanjing 211
Ann Arbor 203
Cambridge 177
Somerville 166
Toronto 144
Serra 142
Andover 140
Sakarya 137
Des Moines 130
Bogotá 121
Boardman 105
Jinan 103
Shenyang 98
Guangzhou 92
Nanchang 80
Kiez 78
Redwood City 76
Shanghai 69
Hebei 62
Berlin 61
Tianjin 60
Saint Petersburg 59
Changsha 57
Nürnberg 53
Hangzhou 47
Athens 45
Roxbury 43
Warsaw 41
Grafing 39
Zhengzhou 38
Hamburg 37
Odernheim 37
Bitonto 36
Kunming 35
Orofino 35
Phoenix 34
Chengdu 32
Payette 32
San Diego 32
Cottonwood 31
Garden Valley 31
Jiaxing 30
Wuhan 30
Jerome 29
Falls Church 28
Hefei 27
Rochester 26
Dong Ket 25
Pisa 25
Silver Spring 24
Lewiston 23
Naples 23
Auburn Hills 21
Fuzhou 20
Verona 19
Lanzhou 18
Norwalk 18
Tokyo 18
San Francisco 17
Parma 16
Scranton 16
Changchun 15
Fremont 15
Ottawa 15
Rome 15
Sunnyvale 15
Geisenheim 14
Taiyuan 14
Brussels 13
Modena 13
Ningbo 13
Seoul 13
Haikou 12
Taizhou 11
Medford 10
Costa Mesa 9
Mainz 9
New York 9
Turin 9
Central District 8
Chesterfield 8
Chongqing 8
Rotterdam 8
Totale 13742
Nome #
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 922
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells : a new attractive target 664
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 300
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 267
Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism 245
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 235
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 221
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 220
Prognostic significance of telomere length in chronic lymphocytic leukemia patients in early stage disease 213
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 207
IMPROVED RISK STRATIFICATION IN MULTIPLE MYELOMA USING A MICRORNA-BASED CLASSIFIER 199
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 186
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 172
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 171
Molecular definition of 17P11-P12 amplification in multiple myeloma 170
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 170
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 169
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia 167
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 165
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 165
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes 165
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 163
Transcriptional features of 1Q in multiple myeloma 161
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 159
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 157
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 150
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 149
Genome-wide approach identify recurrent 8p21.2 loss in more aggressive form of primary plasma-cell leukemia 148
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 148
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 147
B-cell receptor configuration and adverse cytogenetics are associated to a higher risk of autoimmune hemolytic anemia in the course of chronic lymphocytic leukemia 147
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 146
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 145
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 144
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia 144
Molecular classification of Multiple Myeloma : a distinct trascriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation 143
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 143
Genome-wide analysis of DNA copy number in multiple myeloma using high-density SNP arrays reveals clustering patterns with distinct transcriptional profiles 142
Molecular and transcriptional characterization of the novel 17p11-2-p12 chromosome amplification in multiple myeloma 142
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia 142
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 140
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma 139
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing 138
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 134
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 134
Gene expression profiling of plasma cell dyscrasias reveals Multiple Myeloma molecula heterogeneity 133
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 131
Long Non-Coding RNAs in Multiple Myeloma 131
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in the t(4;14) in multiple myeloma 130
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 128
Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma 127
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 127
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 127
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 127
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 126
Molecular classification of multiple myeloma: a distinct profile characterizes patients expressing CCND1 and negative for 14q32 translocations 125
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 125
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 125
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma 124
The immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and rankl/opg ratio in myeloma microenvironment targeting the expression of adhesion molecules 124
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 123
Integrative genomics based on microarrays analyses reveals a correlation between allelic imbalances and gene expression patterns in multiple myeloma 123
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 123
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 122
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 121
Gene expression profiling of isolated mesenchymal and osteoblastic cells exhibits a different pattern of expression in multiple myeloma patients as compared to healthy subjects : potential relationship with the presence of bone lesions 120
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma 120
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 119
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma 119
Transcriptional features of multiple myeloma patients with chromosome 1q gain 118
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 118
Molecular characterization of Multiple Myeloma cell lines : a model for an integrative genomics approach 117
Effect of dioxin (TCDD) on gene transcription of human CD34 + hematopoietic cells 116
Mesenchymal and osteoblastic cells isolated from multiple myeloma patients reveal a different behaviour, phenotype and gene expression profiling in relationship with the presence of osteolytic bone lesions 116
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 116
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 116
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with 13 deletion in Multiple Myeloma 115
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 115
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 115
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 114
Anaplastic lymphoma kinase : meccanismi molecolari e trasformazione linfoide 113
Global SNP-based mapping of B-cell chronic lymphocytic leukemia reveals the role of 2p gain in predicting clinical outcome 112
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 112
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 111
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma 111
Molecular characterization of a panel of Multiple Myeloma cell lines : a model for an integrative genomics approach 110
Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in multiple myeloma patients 110
Biological and clinical relevance of quantitative global methylation in repetitive DNA sequences in B-cell chronic lymphocytic leukemia 110
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia 110
Gene and mirna expression profiles in plasma cell leukemias 110
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 109
Identification of primary MAFB target genes in multiple myeloma 107
The reconstruction of transcriptional regulatory networks reveals critical genes which have implications for clinical outcome of multiple myeloma 105
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma 105
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 104
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 104
Stereotyped B-cell receptor is associated with immune thrombocytopenia in CLL 104
Patterns of global DNA methylation identify early stage (Binet A) CLL patients with higher risk of disease progression 104
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in the T (4;14) in multiple myeloma 103
Totale 15382
Categoria #
all - tutte 28706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181666 0000 352251 68116 198213314154
2018/20192753 58118815747 78284 309150 159183412205
2019/20203347 432144189227 242368 405238 41144016883
2020/20213337 249242227182 294225 187151 413169738260
2021/20222642 20793169149 245185 282170 354206134448
2022/20231424 411263223270 2570 00 0000
Totale 22476